UPC CFI 80/2023
Jun 6, 2023·EP3056564 · METHOD FOR PURIFICATION OF RETINAL PIGMENT EPITHELIAL CELLS
- Case details
- StatusCase Closed (Settled)ActionRevocationCategoryMain revocation action
- Parties
- Claimants
- ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINEOperating co.
Representatives- Mark Didmon-Potter Clarkson
- David Carling
- Oliver Laing-Potter Clarkson
- Nick McDonald-Potter Clarkson
Respondents- Healios K.KOperating co.
- Osaka UniversityUniversity / research
- Division
- Munich CD
- Technology
- ChemistryBiotechnology · Pharmaceuticals
- Language
- English
- First decided
- Oct 11, 2023
- Last decision
- Mar 18, 2024
- EPO Opposition
- STRAWMAN LIMITED2022-04-20
| Patent revoked | Median days to first decision | |
|---|---|---|
| All UPC | 37% (34/91) | 124 |
| Munich CD | Locked | Locked |
| Judge Ulrike Voß | Locked | Locked |
| Judge András Kupecz | Locked | Locked |
| Judge Paolo Gerli | — | Locked |
At the UPC: ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE (4 cases)·Healios K.K (4 cases)
This dispute contains 3 other proceedings
- 2024-03-18Revocation ActionPublic
Summary: Order following the interim conference (R. 105.5 RoP) in the revocation action by Astellas Institute for Regenerative Medicine against Healios K.K. and Osaka University (EP 3 056 564) at the Munich Section of the Central Division. The court confirmed the oral hearing would proceed as planned and admitted a second expert declaration (D21) conditionally, giving the defendant limited time to reply.
Show the legal issues (3)
- Interim conference order under R. 105.5 RoP
- Admissibility of second expert declaration
- Stay of proceedings pending EPO opposition outcome
- 2023-11-20Revocation ActionPublic
Summary: The Munich Central Division refused a request by Healios K.K. and Osaka University to stay UPC revocation proceedings pending a decision by the EPO, finding no concrete near-future date for an EPO decision and holding that the interests of the parties must be weighed, with the claimant's interest in timely proceedings prevailing.
Show the legal issues (3)
- Stay of proceedings (Art. 33(10) UPCA, Rule 295(a) RoP)
- Parallel EPO proceedings
- Discretion to stay
- 2023-11-17Revocation ActionPublic
Summary: The Munich Central Division issued an order on a Rule 262A application by Astellas Institute for Regenerative Medicine to restrict access to a confidential annex, addressing the scope of access permitted to named individuals at the defendant entities Healios K.K. and Osaka University in the revocation action concerning EP 3 056 564.
Show the legal issues (3)
- Confidential information (Rule 262A RoP)
- Access restriction
- Named individual access
- 2023-10-11Revocation ActionPublic
Summary: The Munich Central Division issued a Rule 9 RoP procedural order directing parties to use the CMS and designated workflows for all submissions and limiting external correspondence to a minimum, in the revocation action by Astellas against Healios K.K. and Osaka University.
Show the legal issues (2)
- CMS obligations (Rule 4.1 RoP)
- Electronic service (Rules 278.1, 271.6 RoP)
| Document title | Date | Public |
|---|---|---|
| Case Closure Formal Check | 2025-06-05 | Not public |
| order closing workflow | 2025-06-05 | Public |
| Recording of Oral Hearing - Placeholder | 2024-07-23 | Not public |
| Recording of Oral Hearing - Placeholder | 2024-07-23 | Not public |
| Receipt | 2024-06-20 | Not public |
| Receipt | 2024-06-20 | Not public |
| Confirmation of claimant submissions under R 365 | 2024-06-20 | Not public |
| Confirmation of claimant submissions under R 365 | 2024-06-20 | Not public |
| Receipt | 2024-06-19 | Not public |
| Procedural application pursuant to Rule 365 | 2024-06-19 | Not public |